Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 546-1 (E.D.Tex. Nov. 20, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 546-1 (E.D.Tex. Nov. 20, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 541-1 (E.D.Tex. Nov. 13, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 541-1 (E.D.Tex. Nov. 13, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 541-2 (E.D.Tex. Nov. 13, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 541-2 (E.D.Tex. Nov. 13, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 541-3 (E.D.Tex. Nov. 13, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 541-3 (E.D.Tex. Nov. 13, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-2 (E.D.Tex. Nov. 6, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-2 (E.D.Tex. Nov. 6, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-4 (E.D.Tex. Nov. 6, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-4 (E.D.Tex. Nov. 6, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-3 (E.D.Tex. Nov. 6, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-3 (E.D.Tex. Nov. 6, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-1 (E.D.Tex. Nov. 6, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 536-1 (E.D.Tex. Nov. 6, 2017)
+ More Snippets
Document
IPR2017-00598, No. 8 Reply - Repy to Opposition to Motion for Joinder US 8,629,111 (P.T.A.B. Feb. 10, 2017)
Cite Document
IPR2017-00598, No. 8 Reply - Repy to Opposition to Motion for Joinder US 8,629,111 (P.T.A.B. Feb. 10, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 529-1 (E.D.Tex. Oct. 30, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 529-1 (E.D.Tex. Oct. 30, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 531-1 (E.D.Tex. Oct. 30, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 531-1 (E.D.Tex. Oct. 30, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 530-1 (E.D.Tex. Oct. 30, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 530-1 (E.D.Tex. Oct. 30, 2017)
+ More Snippets
Document
IPR2017-00598, No. 7 Opposition - Patent Owners Opposition to Motion for Joinder (P.T.A.B. Feb. 6, 2017)
Cite Document
IPR2017-00598, No. 7 Opposition - Patent Owners Opposition to Motion for Joinder (P.T.A.B. Feb. 6, 2017)
+ More Snippets
Document
IPR2017-00570, No. 9 Opposition - Patent Owners Opposition to Motion for Joinder (P.T.A.B. Feb. 6, 2017)
Cite Document
IPR2017-00570, No. 9 Opposition - Patent Owners Opposition to Motion for Joinder (P.T.A.B. Feb. 6, 2017)
+ More Snippets
Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 517-2 (E.D.Tex. Oct. 13, 2017)
Cite Document
Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, 2:15-cv-01455, No. 517-2 (E.D.Tex. Oct. 13, 2017)
+ More Snippets